Moderate riskFDA DrugClass III

Macleods Olanzapine 5 mg tablets recalled for elevated impurities

Macleods Pharmaceuticals has recalled Olanzapine Tablets USP 5 mg (lot BOB22321A, expiring 07-31-2027) because testing found organic impurities above acceptable limits. The affected bottles were distributed nationwide. No injuries have been reported.

From the FDA notice · Read the official notice ↗ · All MacLeods Pharma recalls

What to do

  1. Check if you have this medication by looking for lot number BOB22321A on the label.
  2. Contact your pharmacist or doctor if you have affected bottles — do not stop taking your medication without guidance.
  3. Your pharmacy can verify whether your supply is affected and provide replacement or alternative medication if needed.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Olanzapine Tablets, USP 5 mg, 30-count bottle, Rx Only, Manufactured For: Macleods Pharma USA, Inc. Princeton, NJ, 08540; Manufactured by: Macleods Pharmaceuticals, Ltd, Baddi, Himachal Pradesh, INDIA, NDC 33342-068-07.
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
22,032 30-count bottles
Illnesses reported
None reported
Manufactured in
Village Theda, Post Office Lodhimajra, Tehsil Baddi, District Solan, India
Classification
Class III
Recall number
D-0867-2026

In the FDA's words

Description
Olanzapine Tablets, USP 5 mg, 30-count bottle, Rx Only, Manufactured For: Macleods Pharma USA, Inc. Princeton, NJ, 08540; Manufactured by: Macleods Pharmaceuticals, Ltd, Baddi, Himachal Pradesh, INDIA, NDC 33342-068-07. Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification. Lot: BOB22321A, Exp 07-31-2027. Distribution: Nationwide in the USA Affected quantity: 22,032 30-count bottles
Hazard
Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.

Related topics